HOME >> BIOLOGY >> NEWS
Rice, Iowa state biologists search for 'half-fusion'

HOUSTON, May 16, 2005 Every living cell is surrounded by a membrane, a thin barrier that separates the genetic machinery of life from the non-living world outside. Though barriers, membranes are not impervious. Cells use a complex hierarchy of proteins that work in concert to allow cell membranes to fuse with other cells or with membrane-encased packages of proteins and other chemicals that the cell needs to take in or release.

Though well-studied, the molecular details of membrane fusion remain mysterious. In particular, scientists don't understand how holes form between two membranes, but a new study by biochemists at Rice University and Iowa State University offers intriguing new clues about the nature of this process. The study is published in this month's issue of Nature Structural and Molecular Biology.

"Membrane fusion is one of the most basic processes of life," said James McNew, assistant professor of biochemistry and cell biology at Rice University. "It begins at fertilization and occurs billions of times a second in our bodies, and if it ever stops, we die."

For example, inside the cells in our brains, spines and nerves, membranes are used to seal up and transport tiny packets of signaling chemicals from the center of the cell to the outer cell membrane. These packets, or vesicles, wait just inside the cell membrane for the appropriate signal, and once they receive it, they fuse with the membrane and eject their contents into the surrounding tissue, causing an immediate chain reaction that keeps our hearts beating and allows us to move our muscles. Membrane fusion is also used to initiate disease.

"Some invading organisms like enveloped viruses use the fusion process to infect the cell," McNew said.

To understand membrane fusion, it helps to envision the basic structure of membranes. Just five billionths of meter across, membranes are bilayers, meaning they contain two separate layers, or sheets of fatty
'"/>


16-May-2005


Page: 1 2 3

Related biology news :

1. No evidence that widely prescribed statins protect against prostate cancer
2. U-M researchers find family of on switches that cause prostate cancer
3. Waters off Washington state only second place in world where glass sponge reefs found
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. Success rates for prostate cancer depend on experience of surgeon
6. Study identifies a common genetic risk factor for colorectal and prostate cancer
7. Rutgers, Penn researchers capture research dollars to improve prostate cancer diagnostic methods
8. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
9. BRCA2 carriers at increased risk for deadly form of prostate cancer
10. Researchers track how spores break out of dormant state
11. No magic tomato? Study breaks link between lycopene and prostate cancer prevention

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rice Iowa state biologists search for half fusion

(Date:12/17/2014)... Va. , Dec. 15, 2014 ... to make it easier to detect and prevent ... Today the agency started performing an ... capability will validate the authenticity of purchased microcircuits ... The new quality control measures will be conducted ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/17/2014)... AUSTIN, Texas , Dec. 16, 2014  Vermillion, ... company focused on gynecologic disease, today announced the next ... into a premier bio-analytics solutions provider with the naming ... to President and Chief Executive Officer, while current Chairman ... will continue to serve as Chairman. These changes are ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: